Home
>
US Stocks
>
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc
APLS

Apellis Pharmaceuticals Inc (APLS)

$31.3551.15%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
31.76
Today Low/High
30.82 / 31.76
52 Week Low/High
$26.38 / $73
Market Cap
$5.04B

Company Details

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.
Organisation
Apellis Pharmaceuticals Inc
Headquaters
Waltham, Massachusetts, United States
Employees
374
Industry
Distribution Services
CEO
Cedric Francois

Discover more

Frequently Asked Questions

What is Apellis Pharmaceuticals Inc (APLS) share price today?

Can Indians buy Apellis Pharmaceuticals Inc (APLS) shares?

How can I buy Apellis Pharmaceuticals Inc (APLS) shares from India?

Can Fractional shares of Apellis Pharmaceuticals Inc (APLS) be purchased?

What are the documents required to start investing in Apellis Pharmaceuticals Inc (APLS) stocks?

We are a SEBI registered investement advisor